The company announced that Giovanni Caforio, current chief operating officer, will take the place of the outgoing managing director Lamberto Andreotti, in office since 2010 and who will become executive chairman of the board
(Il Sole 24 Ore Radiocor) - New York, 21 January - Change at the top of Bristol-Myers Squibb, but the helm of the American pharmaceutical and biotechnology giant remains in the hands of an Italian.
The company made it known that Giovanni Caforio, current chief operating officer, will take the place of the outgoing managing director Lambert Andreotti, in office since 2010 and who will become executive chairman of the board.
The handover will be effective from May 5th. Caforio joined Bristol-Myers in 2000 as general manager of the Italian division and has since developed a career within the group. In recent years he has in particular followed the marketing of two new drugs for the treatment of cancer and which act on the immune system.
Caphorio he will have to work hard to confirm Bristol-Myers' position on a market that is becoming more and more competitive, also at the hands of its rival Merck. "I aim to build on what we've already achieved, deliver on the promise of our innovative portfolio and continue to make a difference for patients," he said in a statement.
A24-Red
(RADIOCOR) 01-21-15
Ed.: Lambert Andreotti, aged 63, received total compensation of $ 20,847,746 during the 2013 fiscal year.
John Caforio, 49, received total compensation of $ 3,301,852 in the 2013 fiscal year
